Microsoft announces changes to its board, GlaxoSmithKline CEO joining the board
2 min. read
Published on
Share this article
Improve this guide
Read our disclosure page to find out how can you help MSPoweruser sustain the editorial team Read more
Microsoft yesterday announced changes to its board. First, Charles H. Noski, former vice chairman of AT&T Corp. and Bank of America Corp., and Dr. Helmut Panke, former chairman of the board of management at BMW AG are leaving Microsoft board after serving for nearly 16 years. Second, Emma Walmsley, CEO of GlaxoSmithKline (GSK) and member of the GSK board, will be nominated for election at the Microsoft’s annual shareholders meeting on Dec. 4, 2019.
“Emma is an accomplished business leader who led major advances in research and development at GSK and will bring her significant insights and global experience to Microsoft,” said John W. Thompson, Microsoft independent board chair. “We believe she will be a valuable addition to the board.”
“Chuck and Helmut each have brought tremendous wisdom and judgment to our board, including in the vital roles Chuck has played as chair of the Audit Committee and Helmut has played as chair of the Regulatory and Public Policy Committee,” Thompson said.
“Chuck and Helmut have been critical and insightful directors during multiple key moments for Microsoft for more than a decade and a half, and we are grateful for their many contributions,” said Bill Gates, former Microsoft CEO and chairman.
“I very much appreciate the important role that Chuck and Helmut have both played as directors and advisors to me as we’ve pursued Microsoft’s transformation,” said Satya Nadella, Microsoft CEO.
Source: Microsoft
